InsidersTradesSigma
Follow the 동국생명과학 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 동국생명과학 has recorded 1 reports. Market capitalisation: €76.1bn. The latest transaction was filed on 9 April 2026 (Purchase). Among the most active insiders: 김영선. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Dongguk Life Science is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development and manufacturing of biopharmaceutical products.